Functional Brands closes $8 million private placement and completes Nasdaq listing
Amrize Ltd (None:AMRZ) Chief Technology Officer Roald Brouwer reported purchasing shares of the company’s stock on October 31, 2025. The transactions involved the acquisition of 4,000 shares at prices ranging from $51.76 to $51.78, for a total value of $207,100. The purchase comes as the stock currently trades at $51.08, slightly below Brouwer’s acquisition price, with InvestingPro data showing the company has a market capitalization of $28.1 billion and trades at a P/E ratio of 24.3.
Brouwer acquired 3,000 shares at $51.78 and 1,000 shares at $51.76. Following these transactions, Brouwer directly owns 9,000 shares of Amrize Ltd. According to InvestingPro, Amrize maintains a "GOOD" financial health score and has been profitable over the last twelve months with diluted earnings of $2.12 per share. Three analysts have recently revised their earnings expectations upward for the upcoming period. Discover more insights in Amrize’s comprehensive Pro Research Report, available among 1,400+ US equities on InvestingPro.
In other recent news, Amrize AG reported its third-quarter 2025 earnings, showcasing a mixed financial performance. The company posted an earnings per share (EPS) of $0.98, which fell short of the forecasted $1.02, resulting in a negative surprise of 3.92%. However, Amrize’s revenue exceeded expectations, reaching $3.68 billion compared to the anticipated $3.48 billion, marking a positive surprise of 5.75%. This strong revenue performance was a key highlight for investors.
Additionally, Morgan Stanley raised its price target for Amrize Ltd to $61.00 from $60.00, maintaining an Overweight rating on the stock. The investment bank cited improved third-quarter performance, particularly noting good cash generation, volume growth, and margin progression in Amrize’s Envelope segment. These developments reflect a positive outlook from Morgan Stanley despite the EPS miss.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.